Pilocarpine for Sjögren's syndrome-Induced dry mouth and dry eyes a review of clinical effectiveness, cost-effectiveness, and guidelines
This report aims to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines' recommendations for the use of pilocarpine in the treatment of Sjögren's syndrome-induced dry eyes and dry mouth
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
January 21, 2020, 2020
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This report aims to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines' recommendations for the use of pilocarpine in the treatment of Sjögren's syndrome-induced dry eyes and dry mouth |
---|---|
Physical Description: | 1 PDF file (30 pages) illustrations |